(Q48297400)

10 February 2018

title

Current strategies to prevent transmission of prions by human plasma derivatives (English)

1 reference

10 February 2018

0 references

Burnouf T

1

1 reference

10 February 2018

Padilla A

series ordinal

2

1 reference

10 February 2018

publication date

1 November 2006

1 reference

10 February 2018

Transfusion Clinique et Biologique

published in

1 reference

10 February 2018

volume

13

1 reference

10 February 2018

issue

5

1 reference

10 February 2018

page(s)

320-328

1 reference

10 February 2018

Modern plasma fractionation

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Prevalence of lymphoreticular prion protein accumulation in UK tissue samples.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Pathogenesis of prion diseases: current status and future outlook

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

An overview of prion biology and the role of blood filtration in reducing the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Assessment of the potential of plasma fractionation processes to remove causative agents of transmissible spongiform encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

The most infectious prion protein particles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Reducing the risk of infection from plasma products: specific preventative strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Inactivation of transmissible degenerative encephalopathy agents: A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Reduction of transmissible spongiform encephalopathy infectivity from human red blood cells with prion protein affinity ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Transmission of BSE by blood transfusion in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Infectious prions in the saliva and blood of deer with chronic wasting disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Presymptomatic detection of prions in blood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Quality assessment of seven types of fresh-frozen plasma leucoreduced by specific plasma filtration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Residual cell content in plasma produced by three centrifugal apheresis procedures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

A crucial role for B cells in neuroinvasive scrapie.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Validation of prion removal by leucocyte-depleting filters: a cautionary tale.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Chromatography in plasma fractionation: benefits and future trends

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Affinity chromatography in the industrial purification of plasma proteins for therapeutic use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Purity of spiking agent affects partitioning of prions in plasma protein purification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Scrapie removal using Planova virus removal filters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Studies on the removal of a bovine spongiform encephalopathy-derived agent by processes used in the manufacture of human immunoglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Partitioning of human and sheep forms of the pathogenic prion protein during the purification of therapeutic proteins from human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Removal of TSE agents from blood products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

A highly purified factor VIII:c concentrate prepared from cryoprecipitate by ion-exchange chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Properties of a highly purified human plasma factor IX:c therapeutic concentrate prepared by conventional chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Distribution of a bovine spongiform encephalopathy-derived agent over ion-exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIII.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Nanofiltration of plasma-derived biopharmaceutical products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Evaluation of depth filtration to remove prion challenge from an immune globulin preparation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Evaluation of virus and prion reduction in a new intravenous immunoglobulin manufacturing process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Quantitative evaluation of prion inactivation comparing steam sterilization and chemical sterilants: proposed method for test standardization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Novel methods for disinfection of prion-contaminated medical devices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Critical factors influencing prion inactivation by sodium hydroxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Removal of prion challenge from an immune globulin preparation by use of a size-exclusion filter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

Partitioning of TSE infectivity during ethanol fractionation of human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2006.11.001

10.1016/J.TRACLI.2006.11.001

7 January 2021

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018